Amanote Research

Amanote Research

    RegisterSign In

CD16 (FcRγIII) as a Potential Marker of Osteoclast Precursors in Psoriatic Arthritis

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2915
Full Text
Open PDF
Abstract

Available in full text

Categories
RheumatologyAllergyImmunology
Date

January 1, 2010

Authors
Yahui Grace ChiuTianmeng ShaoChangyong FengKofi A MensahMichael ThullenEdward M SchwarzChristopher T Ritchlin
Publisher

Springer Science and Business Media LLC


Related search

AB0761 the Biologic Therapy Use for Enthesitis as a Predictor of Psoriatic Arthritis in Psoriatic Patients

2017English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

007 Upregulation of miR-941 in Peripheral CD14+ Monocytes Enhances Osteoclast Activation and Osteolysis in Patients With Psoriatic Arthritis: A Potential Diagnostic Biomarker and Treatment Target

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy